Summary

The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed countries and unfavorable regulatory scenario are key factors limiting the growth of this market. Product recalls and therapeutic challenges related to the efficacy of ablation products are key challenges faced by industry players in the global ablation technology market.

In terms Application, the cardiovascular treatment segment is expected to account for the largest share of the ablation technology market in 2020.”
Based on application, the ablation technology market is classified into major segments—cardiovascular disease treatment, cancer treatment, ophthalmological treatment, pain management, gynecological treatment, urological treatment, orthopedic treatment, cosmetic/aesthetic surgery, and other applications. Rising disease prevalence and technological advancement in this field will boost market growth.
“In terms of product segment, radiofrequency ablators segment is expected to account for the largest share during the forecast period.”
Based on product, the global ablation technology market is classified into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators/hydromechanical ablators. Each product class is further segmented based on its applications or source of energy.
The large share of radiofrequency ablators segment is attributed to the introduction of novel products by major market players and the increasing adoption of RF ablation technology to treat various conditions, such as cancer, cardiac diseases, and ophthalmic diseases.

“In terms of type segment, radiofrequency ablation segment is expected to account for the largest share during the forecast period.”
Based on the type of energy source, the global ablation technology market is classified into light/laser, radiofrequency (RF), electrical, ultrasound, microwave, cryotherapy, and hydrothermal/hydromechanical ablation technologies. The lower cost of radiofrequency ablation, its ease of use, and the rising geriatric population fuel the growth of the radiofrequency ablation market.
“The hospitals, surgical centers, and ablation centers segment is expected to register the highest CAGR during the forecast period” `
The ablation technology market, by end user, is segmented into hospitals, surgical centers, and ablation centers, ambulatory surgical centers (ASCs), medical spas & aesthetic centers, and other end users. The increasing incidence of cancer, sports injuries, and cardiac conditions is driving the growth of the ablation technology market for hospitals, surgical centers, and ablation centers segment.
Asia Pacific market is expected to grow at the highest CAGR during the forecast period.”
The ablation technology market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the ablation technology market. The market growth in Asia Pacific can be attributed rising incidence and prevalence of cancer and cardiac conditions, technological advancement in ablation product and technology, increasing awareness of minimally invasive techniques and growth opportunities in the emerging markets.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–20%, Tier 2–45%, and Tier 3– 35%
• By Designation: C-level–30%, Director-level–20%, and Others–50%
• By Region: North America–36%, Europe–25%, Asia Pacific–27%, Latin America–9%, and the Middle East & Africa–3%

The prominent players in the ablation technology market include Medtronic, plc. (Ireland), Johnson & Johnson (US), Abbott (US), and Boston Scientific Corporation (US) and CONMED Corporation (US), AngioDynamics, Inc. (US), AtriCure, Inc. (US), Smith & Nephew plc (UK), Olympus Corporation (Japan), Varian Medical Systems (UK), Stryker (US), Dornier MedTech (Germany), Cynosure (US) and InMode (US).
Research Coverage

This report studies the ablation technology market based on type, product, application, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to five major regions and their respective major countries.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the products offered by the top players in the ablation technology market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ablation technology market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in ablation technology market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 GEOGRAPHIC SCOPE 32
1.3.3 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY 33
TABLE 1 STANDARD CURRENCY CONVERSION RATES 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN METHODOLOGY 35
2.1.1 SECONDARY RESEARCH 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY RESEARCH 38
FIGURE 2 PRIMARY SOURCES 38
2.1.2.1 Key data from primary sources 39
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS:
BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 TOTAL MARKET SIZE: ABLATION TECHNOLOGY MARKET 41
2.2.1.1 Bottom-up approach 41
FIGURE 5 MARKET SIZE ESTIMATION: ABLATION TECHNOLOGY MARKET
(BOTTOM-UP APPROACH) 42
2.2.1.2 Growth forecast 42
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.2.2 MARKET SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION,
AND END USER) 43
FIGURE 7 TOP-DOWN APPROACH 43
2.2.3 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY) 44
2.2.4 PRIMARY RESEARCH VALIDATION 44
2.3 COVID-19 HEALTH ASSESSMENT 44
2.4 COVID-19 ECONOMIC ASSESSMENT 45

2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 45
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 45
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 46
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ABLATION TECHNOLOGY MARKET 47
2.7 MARKET BREAKDOWN AND DATA TRIANGULATION 48
FIGURE 10 ABLATION TECHNOLOGY MARKET: DATA TRIANGULATION METHODOLOGY 48
2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS 49
2.8.1 ASSUMPTIONS FOR THE STUDY 49
2.9 RISK ASSESSMENT 49
TABLE 2 RISK ASSESSMENT: ABLATION TECHNOLOGY MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 11 ABLATION TECHNOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 12 ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 51
FIGURE 13 ABLATION TECHNOLOGY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 51
FIGURE 14 ABLATION TECHNOLOGY MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 52
4 PREMIUM INSIGHTS 53
4.1 ABLATION TECHNOLOGY MARKET OVERVIEW 53
FIGURE 15 EXPANSION OF THE TARGET POPULATION TO DRIVE MARKET GROWTH 53
4.2 ABLATION TECHNOLOGY MARKET, BY PRODUCT 54
FIGURE 16 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE
THE ABLATION TECHNOLOGY MARKET BY 2026 54
4.3 ABLATION TECHNOLOGY MARKET, BY END USER 54
FIGURE 17 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE
THE LARGEST END USERS OF ABLATION TECHNOLOGY 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Increasing demand for minimally invasive/non-invasive procedures 55
5.2.1.2 The emergence of next-generation ablation products & technologies 56
5.2.1.3 Expansion of the target patient population 57
5.2.1.3.1 Rapid growth in the aging population with a higher risk of targeted diseases 57
TABLE 3 GERIATRIC POPULATION, BY REGION, 2015 VS 2030 57
5.2.1.3.2 Growing incidence of sports injuries and cancer 58
5.2.1.3.3 Growing prevalence of atrial fibrillation and other cardiac conditions 59
5.2.1.4 The increasing number of hospitals and surgical & ablation centers 59
5.2.2 RESTRAINTS 60
5.2.2.1 Insufficient evidence and unfavorable regulatory scenario 60
5.2.2.2 Strong market positioning of alternative therapies 60
TABLE 5 ALTERNATIVE THERAPIES/PROCEDURES TO ABLATION 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth potential in emerging economies 61
5.2.4 CHALLENGES 62
5.2.4.1 Product recalls 62
5.2.4.2 Reuse and reprocessing of devices 62
5.2.4.3 Therapeutic challenges and hazardous effects of ablation 63
5.3 REGULATORY LANDSCAPE 64
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ABLATION DEVICES 64
5.3.1 NORTH AMERICA 65
5.3.1.1 US 65
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 65
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 66
5.3.1.2 Canada 66
FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 67
5.3.2 EUROPE 68
FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.3.3 ASIA PACIFIC 70
5.3.3.1 Japan 70
TABLE 10 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES 70
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 70
5.3.3.2 China 71
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 71
5.3.3.3 India 72
TABLE 13 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES 73
5.4 VALUE CHAIN ANALYSIS 73
FIGURE 22 VALUE CHAIN ANALYSIS OF THE ABLATION TECHNOLOGY MARKET 73
5.5 SUPPLY CHAIN ANALYSIS 74
TABLE 14 SUPPLY CHAIN ECOSYSTEM 74
5.6 ECOSYSTEM COVERAGE: PARENT MARKET 75
5.7 REIMBURSEMENT SCENARIO 75
TABLE 15 MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN
THE US (EFFECTIVE JANUARY 1, 2021) 76
5.8 PRICING TREND ANALYSIS 77
5.9 TRADE ANALYSIS 78
5.9.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES 78
TABLE 16 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,
2016–2020 (USD BILLION) 78
5.10 PORTER’S FIVE FORCE ANALYSIS 78
TABLE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 78
5.10.1 THREAT FROM NEW ENTRANTS 79
5.10.2 THREAT OF SUBSTITUTES 79
5.10.3 BARGAINING POWER OF SUPPLIERS 80
5.10.4 BARGAINING POWER OF BUYERS 80
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.11 COVID-19 IMPACT ON THE ABLATION TECHNOLOGY MARKET 81
6 ABLATION TECHNOLOGY MARKET, BY TYPE 83
6.1 INTRODUCTION 84
TABLE 18 ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 84
6.2 RADIOFREQUENCY ABLATION 84
6.2.1 THE LOW COST OF RADIOFREQUENCY ABLATION CONTRIBUTES TO MARKET GROWTH 84
TABLE 19 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET,
BY REGION, 2019–2026 (USD MILLION) 85
6.3 LASER/LIGHT ABLATION 86
6.3.1 HIGH EFFICACY AND SAFETY DRIVE THE ADOPTION OF LASER/LIGHT ABLATION 86
TABLE 20 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 86
6.4 ULTRASOUND ABLATION 86
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE ULTRASOUND ABLATION SEGMENT WILL BOOST MARKET GROWTH 86
TABLE 21 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 87
6.5 ELECTRICAL ABLATION 87
6.5.1 THE USE OF ELECTRICAL ABLATION TECHNOLOGY IN CARDIOVASCULAR AND CANCER CONDITIONS WILL BOOST MARKET GROWTH 87
TABLE 22 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 88
6.6 CRYOABLATION 88
6.6.1 INCREASING FOCUS ON COSMETIC SURGERY IS A KEY MARKET GROWTH DRIVER 88
TABLE 23 CRYOABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 89

6.7 MICROWAVE ABLATION 89
6.7.1 ADVANTAGES OVER RF ABLATION WILL ENSURE DEMAND FOR MICROWAVE ABLATION 89
TABLE 24 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 90
6.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION 90
6.8.1 INCREASING USAGE IN GYNECOLOGY WILL HELP IN MARKET GROWTH 90
TABLE 25 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,
BY REGION, 2019–2026 (USD MILLION) 91
7 ABLATION TECHNOLOGY MARKET, BY PRODUCT 92
7.1 INTRODUCTION 93
TABLE 26 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 93
7.2 RADIOFREQUENCY ABLATORS 93
TABLE 27 RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 28 RADIOFREQUENCY ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 94
7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS 94
7.2.1.1 Clinical advantages of temperature-controlled RF ablators over traditional approaches are driving the market 94
TABLE 29 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET,
BY REGION, 2019–2026 (USD MILLION) 95
7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS 95
7.2.2.1 Better temperature control as compared to other traditional radiofrequency ablators 95
TABLE 30 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS 96
7.2.3.1 The effectiveness of remote catheter manipulators in AF will propel market growth 96
TABLE 31 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
7.3 LASER/LIGHT ABLATORS 97
TABLE 32 LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 33 LASER/LIGHT ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 97
7.3.1 EXCIMER LASER ABLATORS 98
7.3.1.1 Increasing use of excimer laser ablators in ophthalmological applications is a key driver of the market 98
TABLE 34 EXCIMER LASER ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 98
7.3.2 COLD LASER ABLATORS 98
7.3.2.1 Cold laser ablator treatment releases endorphins to support pain management 98
TABLE 35 COLD LASER ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 99
7.4 ULTRASOUND ABLATORS 99
TABLE 36 ULTRASOUND ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 99
TABLE 37 ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 100
7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS 100
7.4.1.1 Ultrasonic surgical ablators dominate the ultrasound ablators market 100
TABLE 38 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 100
7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS 101
7.4.2.1 Low procedural times and reduced bleeding support product adoption 101
TABLE 39 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 101
7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS 101
7.4.3.1 Growing incidence of obesity and diabetes drive the market growth 101
TABLE 40 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET,
BY REGION, 2019–2026 (USD MILLION) 102
7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS 102
7.4.4.1 A combination of techniques allows for high efficacy 102
TABLE 41 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 103
7.5 ELECTRICAL ABLATORS 103
TABLE 42 ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 43 ELECTRICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 104
7.5.1 ARGON PLASMA/BEAM COAGULATORS 104
7.5.1.1 Increasing preference for APC is a key driver of the market 104
TABLE 44 ARGON PLASMA/BEAM COAGULATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS 105
7.5.2.1 IRE provides selective targeting and better control 105
TABLE 45 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
7.6 CRYOABLATION DEVICES 106
TABLE 46 CRYOABLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 47 CRYOABLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 106
7.6.1 TISSUE CONTACT PROBES 106
7.6.1.1 The safety and effectiveness of tissue contact probes have driven their use 106
TABLE 48 TISSUE CONTACT PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 107
7.6.2 TISSUE SPRAY PROBES 107
7.6.2.1 The ability to treat surgically inoperable tumors is driving the use of spray probes 107
TABLE 49 TISSUE SPRAY PROBES MARKET, BY REGION, 2019–2026 (USD MILLION) 107
7.6.3 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES 108
7.6.3.1 Anesthetic properties of epidermal & subcutaneous probes are supporting market growth 108
TABLE 50 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 108
7.7 MICROWAVE ABLATORS 108
TABLE 51 MICROWAVE ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 109
7.7.1 MICROWAVE THERMOTHERAPY DEVICES 109
7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATORS 110
TABLE 52 HYDROTHERMAL/HYDROMECHANICAL ABLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 110
7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES 110
8 ABLATION TECHNOLOGY MARKET, BY APPLICATION 111
8.1 INTRODUCTION 112
TABLE 53 ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
8.2 CARDIOVASCULAR DISEASE TREATMENT 112
8.2.1 THE GROWTH OF THE TARGET PATIENT POPULATION WILL CONTINUE TO PROPEL THE DEMAND FOR CARDIAC ABLATION DEVICES 112
TABLE 54 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2019–2026 (USD MILLION) 113
8.3 CANCER TREATMENT 113
8.3.1 RISING PREVALENCE OF CANCER TO PROPEL MARKET GROWTH 113
TABLE 55 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION,
2015–2019 114
8.3.2 LIVER CANCER 114
8.3.3 KIDNEY CANCER 114
8.3.4 PROSTATE CANCER 114
8.3.5 LUNG CANCER 115
8.3.6 BONE METASTASIS 115
8.3.7 BREAST CANCER 115
TABLE 56 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2019–2026 (USD MILLION) 115
8.4 ORTHOPEDIC TREATMENT 115
8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION DRIVE DEMAND FOR ABLATION IN ORTHOPEDIC TREATMENT 115
TABLE 57 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2026 (USD MILLION) 116
8.5 COSMETIC/AESTHETIC SURGERY 116
8.5.1 COSMETIC/AESTHETIC SURGERY TO SEE HIGH GROWTH IN THE COMING YEARS 116
TABLE 58 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,
BY REGION, 2019–2026 (USD MILLION) 117
8.6 UROLOGICAL TREATMENT 117
8.6.1 THE HIGH PREVALENCE OF KIDNEY STONES IS A PROMINENT DRIVER OF MARKET GROWTH 117
TABLE 59 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2019–2026 (USD MILLION) 118

8.7 GYNECOLOGICAL TREATMENT 118
8.7.1 INCREASING PREVALENCE OF GYNECOLOGICAL CONDITIONS AND REPRODUCTIVE HEALTH CONCERNS TO BOOST MARKET GROWTH 118
TABLE 60 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT,
BY REGION, 2019–2026 (USD MILLION) 119
8.8 PAIN MANAGEMENT 119
8.8.1 RISING DEMAND OF MIS TO HELP SUSTAIN MARKET GROWTH 119
TABLE 61 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT,
BY REGION, 2019–2026 (USD MILLION) 120
8.9 OPHTHALMOLOGICAL TREATMENT 120
8.9.1 THE RISING PREVALENCE OF VISION DISORDERS AND GROWING POPULATION WILL DRIVE THE MARKET GROWTH 120
TABLE 62 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,
BY REGION, 2019–2026 (USD MILLION) 121
8.10 OTHER APPLICATIONS 121
TABLE 63 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 121
9 ABLATION TECHNOLOGY MARKET, BY END USER 122
9.1 INTRODUCTION 123
TABLE 64 ABLATION TECHNOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION) 123
9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS 123
9.2.1 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE MAJOR END USERS OF THE MARKET 123
TABLE 65 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2019–2026 (USD MILLION) 124
9.3 AMBULATORY SURGICAL CENTERS 124
9.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY CARE AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES 124
TABLE 66 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2013–2018) 125
TABLE 67 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2019–2026 (USD MILLION) 125
9.4 MEDICAL SPAS & AESTHETIC CLINICS 125
9.4.1 MEDICAL SPAS & AESTHETIC CLINICS OFFER ABLATION SERVICES FOR ENHANCING THE BEAUTY AND OVERALL WELLNESS OF THE BODY 125
TABLE 68 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS & AESTHETIC CLINICS, BY REGION, 2019–2026 (USD MILLION) 126
9.5 OTHER END USERS 126
TABLE 69 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 126
10 ABLATION TECHNOLOGY MARKET, BY REGION 127
10.1 INTRODUCTION 128
TABLE 70 ABLATION TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION) 128
10.2 NORTH AMERICA 128
FIGURE 23 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT 129
TABLE 71 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 72 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 73 NORTH AMERICA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 74 NORTH AMERICA: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 75 NORTH AMERICA: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 76 NORTH AMERICA: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 77 NORTH AMERICA: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 78 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 132
TABLE 79 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 133
10.2.1 US 133
10.2.1.1 The rising prevalence of cancer and CVD will propel market growth 133
TABLE 80 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
10.2.2 CANADA 134
10.2.2.1 The high burden of cancer supports market growth 134
TABLE 81 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
10.3 EUROPE 135
TABLE 82 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 136
TABLE 83 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 136
TABLE 84 EUROPE: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 85 EUROPE: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 86 EUROPE: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 87 EUROPE: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 88 EUROPE: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 89 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 90 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.3.1 GERMANY 139
10.3.1.1 Highly developed healthcare infrastructure and rising disease incidence ensure strong growth prospects 139
TABLE 91 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
10.3.2 FRANCE 140
10.3.2.1 Growing geriatric population to support market growth in France 140
TABLE 92 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION 141
10.3.3 UK 141
10.3.3.1 Rising geriatric population is supporting the market growth in the UK 141
TABLE 93 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
10.3.4 ITALY 142
10.3.4.1 Rising awareness to support market growth 142
TABLE 94 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
10.3.5 SPAIN 143
10.3.5.1 Increasing government funding for research to support market growth 143
TABLE 95 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 96 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
10.4 ASIA PACIFIC 146
FIGURE 24 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT 146
TABLE 97 APAC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 98 APAC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 99 APAC: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 100 APAC: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 101 APAC: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 102 APAC: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 103 APAC: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 104 APAC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 150
TABLE 105 APAC: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 150
10.4.1 JAPAN 151
10.4.1.1 Presence of universal healthcare reimbursement scenario and growing geriatric population—key factors driving market growth 151
TABLE 106 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
10.4.2 CHINA 152
10.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth 152
TABLE 107 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
10.4.3 INDIA 153
10.4.3.1 Ongoing modernization and infrastructure development in India to support the market growth 153
TABLE 108 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
10.4.4 AUSTRALIA 153
10.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth 153
TABLE 109 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
10.4.5 SOUTH KOREA 154
10.4.5.1 Rising R&D and promising clinical trials in the country to positively impact market growth 154
TABLE 110 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
10.4.6 REST OF ASIA PACIFIC 155
TABLE 111 ROAPAC: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
10.5 LATIN AMERICA 156
TABLE 112 LATAM: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 156
TABLE 113 LATAM: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 114 LATAM: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 115 LATAM: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 116 LATAM: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 117 LATAM: ELECTRICAL ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 118 LATAM: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 119 LATAM: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 159
TABLE 120 LATAM: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 159
10.5.1 BRAZIL 160
10.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities 160
TABLE 121 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
10.5.2 MEXICO 160
10.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico 160
TABLE 122 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
10.5.3 REST OF LATIN AMERICA 161
TABLE 123 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
10.6 MIDDLE EAST & AFRICA 162
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 162
TABLE 124 MEA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 125 MEA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 126 MEA: LASER/LIGHT ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 127 MEA: ULTRASOUND ABLATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 128 MEA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 129 MEA: CRYOABLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 130 MEA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 131 MEA: ABLATION TECHNOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 166
11 COMPETITIVE LANDSCAPE 167
11.1 OVERVIEW 167
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 167
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY KEY ABLATION TECHNOLOGY PROVIDERS 168
11.3 REVENUE SHARE ANALYSIS 169
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET 169
11.4 MARKET SHARE ANALYSIS 170
FIGURE 27 MEDTRONIC HELD THE LEADING POSITION IN
THE ABLATION TECHNOLOGY MARKET IN 2020 170
TABLE 132 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION 170
11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 171
11.5.1 STARS 171
11.5.2 PERVASIVE PLAYERS 171
11.5.3 EMERGING LEADERS 171
11.5.4 PARTICIPANTS 171
FIGURE 28 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020 172
11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 172
11.6.1 PROGRESSIVE COMPANIES 172
11.6.2 STARTING BLOCKS 172
11.6.3 RESPONSIVE COMPANIES 173
11.6.4 DYNAMIC COMPANIES 173
FIGURE 29 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION
QUADRANT FOR SMES/START-UPS, 2020 173
11.7 COMPETITIVE BENCHMARKING 174
FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE
TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET 174
TABLE 133 COMPANY APPLICATION FOOTPRINT 174
TABLE 134 COMPANY REGIONAL FOOTPRINT 175
11.8 COMPETITIVE SCENARIO AND TRENDS 175
11.8.1 PRODUCT LAUNCHES & APPROVALS 175
11.8.2 DEALS 176
11.8.3 OTHER DEVELOPMENTS 176
12 COMPANY PROFILES 177
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 177
12.1.1 MEDTRONIC 177
TABLE 135 MEDTRONIC: BUSINESS OVERVIEW 177
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT 178
TABLE 136 MEDTRONIC: PRODUCT OFFERINGS 178
12.1.2 JOHNSON & JOHNSON 182
TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW 182
FIGURE 32 JOHNSON & JOHNSON: COMPANY SNAPSHOT 183
TABLE 138 JOHNSON & JOHNSON: PRODUCT OFFERINGS 183
12.1.3 ABBOTT LABORATORIES 186
TABLE 139 ABBOTT LABORATORIES: BUSINESS OVERVIEW 186
FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT 186
TABLE 140 ABBOTT LABORATORIES: PRODUCT OFFERINGS 187
12.1.4 BOSTON SCIENTIFIC CORPORATION 188
TABLE 141 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 188
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 189
TABLE 142 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS 189
12.1.5 ANGIODYNAMICS 191
TABLE 143 ANGIODYNAMICS: BUSINESS OVERVIEW 191
FIGURE 35 ANGIODYNAMICS: COMPANY SNAPSHOT 192
TABLE 144 ANGIODYNAMICS: PRODUCT OFFERINGS 192
12.1.6 ATRICURE 194
TABLE 145 ATRICURE: BUSINESS OVERVIEW 194
FIGURE 36 ATRICURE: COMPANY SNAPSHOT 194
TABLE 146 ATRICURE: PRODUCT OFFERINGS 194
12.1.7 CONMED CORPORATION 196
TABLE 147 CONMED: BUSINESS OVERVIEW 196
FIGURE 37 CONMED CORPORATION: COMPANY SNAPSHOT 197
TABLE 148 CONMED: PRODUCT OFFERINGS 197
12.1.8 OLYMPUS CORPORATION 198
TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW 198
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT 199
TABLE 150 OLYMPUS CORPORATION: PRODUCT OFFERINGS 199
12.1.9 SMITH & NEPHEW 201
TABLE 151 SMITH & NEPHEW: BUSINESS OVERVIEW 201
FIGURE 39 SMITH & NEPHEW: COMPANY SNAPSHOT 202
TABLE 152 SMITH & NEPHEW: PRODUCT OFFERINGS 202
12.1.10 STRYKER CORPORATION 203
TABLE 153 STRYKER: BUSINESS OVERVIEW 203
FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT 204
TABLE 154 STRYKER: PRODUCT OFFERINGS 204
12.1.11 DORNIER MEDTECH 206
TABLE 155 DORNIER MEDTECH: BUSINESS OVERVIEW 206
TABLE 156 DORNIER MEDTECH: PRODUCT OFFERINGS 206
12.1.12 CYNOSURE 208
TABLE 157 CYNOSURE: BUSINESS OVERVIEW 208
TABLE 158 CYNOSURE: PRODUCT OFFERINGS 208
12.1.13 VARIAN MEDICAL SYSTEMS 209
TABLE 159 VARIAN MEDICAL SYSTEMS: BUSINESS OVERVIEW 209
FIGURE 41 VARIAN MEDICAL SYSTEMS.: COMPANY SNAPSHOT 210
TABLE 160 VARIAN MEDICAL SYSTEMS: PRODUCT OFFERINGS 210
12.1.14 INMODE 213
TABLE 161 INMODE: BUSINESS OVERVIEW 213
FIGURE 42 INMODE: COMPANY SNAPSHOT 213
TABLE 162 INMODE: PRODUCT OFFERINGS 214
12.2 OTHER COMPANIES 216
12.2.1 EDAP TMS 216
12.2.2 LUMENIS 216
12.2.3 ARTHREX 217
12.2.4 ICECURE 217
12.2.5 MERIT MEDICAL 218
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 219
13.1 DISCUSSION GUIDE 219
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
13.3 AVAILABLE CUSTOMIZATIONS 227
13.4 RELATED REPORTS 227
13.5 AUTHOR DETAILS 228